Literature DB >> 18839011

Denosumab--a novel strategy to prevent structural joint damage in patients with RA?

Georg Schett1, Jean-Pierre David.   

Abstract

Entities:  

Year:  2008        PMID： 18839011     DOI： 10.1038/ncprheum0927

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  3 in total

1.  Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF-kappaB-dependent pathway.

Authors:  Susan Z Y Lo; James H Steer; David A Joyce
Journal:  Arthritis Res Ther       Date:  2011-02-15       Impact factor: 5.156

2.  Binding Immunoglobulin Protein (BIP) Inhibits TNF-α-Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis Model.

Authors:  Mario M Zaiss; Christopher Hall; Neil W A McGowan; Rebecca Babb; Vikesh Devlia; Sébastien Lucas; Sajeda Meghji; Brian Henderson; Aline Bozec; Georg Schett; Jean-Pierre David; Gabriel S Panayi; Agamemnon E Grigoriadis; Valerie M Corrigall
Journal:  ACR Open Rheumatol       Date:  2019-08-03

3.  Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation.

Authors:  Jyoti Das; Guangwen Ren; Liying Zhang; Arthur I Roberts; Xin Zhao; Alfred L M Bothwell; Luc Van Kaer; Yufang Shi; Gobardhan Das
Journal:  J Exp Med       Date:  2009-09-28       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.